- Accuray is the first industry partner to open a facility at the
Genolier Innovation Hub, created to provide opportunities for
clinician-industry collaborations that can help accelerate
improvements in patient care
- New Accuray CyberComm™ tool was used to significantly reduce
the CyberKnife® S7™ System's commissioning time and
enable product training in Genolier to begin more quickly
MADISON,
Wis., Sept. 30, 2024 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today the initiation of
CyberKnife® S7™ System medical professional training at
its education center located within the newly opened Genolier
Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in Switzerland. As the first industry partner to
have a presence at the hub, Accuray now offers product training,
and facilitates sharing of best practices and innovative
techniques, on both its CyberKnife and Radixact®
Radiation Treatment Delivery Systems. Accuray began hosting
Radixact System educational courses earlier in 2024.
A three-day series of events marked the grand opening of the
state-of-the-art Genolier Innovation Hub, unique in Europe. "We congratulate the Genolier
Innovation Hub team on the launch of their new facility and
network. They are changing the model for cross-disciplinary
collaboration in support of advancing patient care," said
Sandeep Chalke, interim CEO &
Senior Vice President, Chief Commercial Officer, at Accuray.
Continued Mr. Chalke, "We opened our European education center
within the hub to expand access to advanced training to more
Accuray CyberKnife and Radixact System users. We are committed to
improving the lives of people diagnosed with cancer and this goal
is intricately linked to our customers' ability to optimize their
use of our systems. The opportunity to easily access training, such
as the courses we offer at our center in Genolier, is critical to
their success."
The Accuray education center in Genolier was designed from the
ground up to provide a comprehensive learning experience. The
training curriculum is created to reflect the distinctive needs of
the diverse medical professionals involved in the care of patients
treated using radiosurgery and radiotherapy. Course attendees have
access to expert instructors and hands-on simulation facilities for
training and demonstrations of the CyberKnife and Radixact
Systems.
The CyberKnife and Radixact Systems have complementary clinical
applications with the same goal: to empower customers to deliver
the most precise and accurate treatments while still minimizing
dose to healthy tissue, helping to reduce the risk of side effects
that may impact patients' quality of life. The systems include
advanced functionality that make it easier and more efficient to
administer extremely precise radiation treatments, even to targets
that move, providing the medical care team with options for
managing the full spectrum of cancer cases, from routine to complex
and initial treatment to retreatment, and neurologic disorders.
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions designed to deliver radiation
treatments for even the most complex cases—while making commonly
treatable cases even easier—to meet the full spectrum of patient
needs. We are dedicated to continuous innovation in radiation
therapy for oncology, neuro-radiosurgery, and beyond, as we partner
with clinicians and administrators, empowering them to help
patients get back to their lives, faster. Accuray is headquartered
in Madison, Wisconsin, with
facilities worldwide. To learn more, visit www.accuray.com or
follow us on Facebook, LinkedIn, X, and YouTube.
Safe Harbor Statement
Statements made in this press release that are not statements of
historical fact are forward-looking statements and are subject to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited to, expectations related to
expectations regarding the Genolier Innovation Hub and the
Company's education center located within Genolier; expectations
regarding the Company's training curriculum; and expectations
regarding the Company's products. These risks and uncertainties
include, but are not limited to, the effect of the current global
economic environment, including in connection to the COVID-19
pandemic, on the operations of the company and those of its
customers and suppliers; the company's ability to achieve
widespread market acceptance of its products; the company's ability
to develop new products or improve existing products to meet
customers' needs; the company's ability to anticipate or keep pace
with changes in the marketplace and the direction of technological
innovation and customer demands; reliance on third party
collaborators, partnerships, strategic alliances and joint
ventures; and such other risks identified under the heading "Risk
Factors" in the company's Annual Report on Form 10-K, filed with
the Securities and Exchange Commission (the "SEC") on September 19, 2024, and as updated periodically
with the company's other filings with the SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to the
company at the time those statements are made and/or management's
good faith belief as of that time with respect to future events.
The company assumes no obligation to update forward-looking
statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities
laws. Accordingly, investors should not put undue reliance on any
forward-looking statements.
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-celebrates-opening-of-genolier-innovation-hub-in-switzerland-initiation-of-cyberknife-s7-system-medical-professional-training-302262088.html
SOURCE Accuray Incorporated